AI assistant
Cartesian Therapeutics, Inc. — Director's Dealing 2016
Jun 22, 2016
33483_dirs_2016-06-21_08a4685e-490a-48fe-b605-cd06f1585773.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2016-06-21
Reporting Person: CAUTREELS WERNER (Director, President and CEO, 10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 301203 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $6.40 | 2025-12-04 | Common Stock (123076) | Direct | |
| Employee Stock Option (right to buy) | $8.97 | 2024-04-07 | Common Stock (57692) | Direct | |
| Employee Stock Option (right to buy) | $2.77 | 2023-06-13 | Common Stock (16613) | Direct | |
| Employee Stock Option (right to buy) | $3.44 | 2022-03-29 | Common Stock (41025) | Direct |
Footnotes
F1: Includes 3,439 shares of restricted common stock which are subject to a right of repurchase by the issuer.
F2: This option vests in 48 substantially equal monthly installments beginning on December 4, 2015.
F3: The option vested as to 25% of the shares on January 1, 2015. The remainder of the shares vested or will vest in 36 substantially equal monthly installments thereafter.
F4: The option vested as to 25% of the shares on January 1, 2014. The remainder of the shares vested or will vest in 36 substantially equal monthly installments thereafter.
F5: All shares underlying this option are fully vested.